Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Al...

by Hao Xie, Jacqueline M. Lafky, Bruce W. Morlan, Philip J. Stella, Shaker R. Dakhil, Gerald G. Gross, William S. Loui, Joleen M. Hubbard, Steven R. Alberts, Axel Grothey
Published 2020-03-01

Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma

by Andre T. Baron, Nita J. Maihle, Ping Yang, Adam J. Branscum, Yuxia Wang, Marites C. Buenafe, Kimberly D. Kimbler, Tammy M. Greenwood, Abby L. Cosentino-Boehm, Jacqueline M. Lafky
Published 2013-01-01